Evidence map›Paper›PMID 42747427›Full record

ArticleeLife2026

A systematic interactome of

Pierre Luciano, Kihyun Park, Stephane Audebert, Luc Camoin, Carlos A Niño, Da Kyeong Park, Isabella E Maudlin, Marion Dubarry, Lara Lee, Marlene Oeffinger and 5 more

Abstract read
In one paragraph

Article in eLife, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Pierre Luciano *Marseille Cancer Research Center (CRCM), U1068 Inserm, UMR7258 CNRS, Aix Marseille University, Institut Paoli-Calmettes, Marseille, France.ORCID https://orcid.org/0000-0002-1394-4129
Kihyun Park *Department of Biological Sciences, Korea Advanced Institute of Science and Technology, Daejeon, Republic of Korea.ORCID https://orcid.org/0000-0001-7841-624X
Stephane AudebertMarseille Cancer Research Center (CRCM), U1068 Inserm, UMR7258 CNRS, Aix Marseille University, Institut Paoli-Calmettes, Marseille, France.
Luc CamoinMarseille Cancer Research Center (CRCM), U1068 Inserm, UMR7258 CNRS, Aix Marseille University, Institut Paoli-Calmettes, Marseille, France.ORCID https://orcid.org/0000-0002-1230-4787
Carlos A NiñoMarseille Cancer Research Center (CRCM), U1068 Inserm, UMR7258 CNRS, Aix Marseille University, Institut Paoli-Calmettes, Marseille, France.ORCID https://orcid.org/0000-0002-4537-0596
Da Kyeong ParkOchang Institute of Biological and Environmental Science, Korea Basic Science Institute, Cheongju, Republic of Korea.
Isabella E MaudlinWellcome Centre for Cell Biology and Institute of Cell Biology, School of Biological Sciences, University of Edinburgh, Edinburgh, United Kingdom.
Marion DubarryMarseille Cancer Research Center (CRCM), U1068 Inserm, UMR7258 CNRS, Aix Marseille University, Institut Paoli-Calmettes, Marseille, France.ORCID https://orcid.org/0000-0001-5648-5770
Lara LeeMarseille Cancer Research Center (CRCM), U1068 Inserm, UMR7258 CNRS, Aix Marseille University, Institut Paoli-Calmettes, Marseille, France.
Marlene OeffingerInstitut de recherches cliniques de Montréal, Center for Genetic and Neurological Diseases, Montréal, Canada.
Jean D BeggsWellcome Centre for Cell Biology and Institute of Cell Biology, School of Biological Sciences, University of Edinburgh, Edinburgh, United Kingdom.
Young Hye KimOchang Institute of Biological and Environmental Science, Korea Basic Science Institute, Cheongju, Republic of Korea.
Jaehoon KimDepartment of Biological Sciences, Korea Advanced Institute of Science and Technology, Daejeon, Republic of Korea.ORCID https://orcid.org/0000-0003-4035-0438
Bernhard DichtlSchool of Life and Environmental Sciences, Deakin University, Geelong, Australia.
Vincent GeliMarseille Cancer Research Center (CRCM), U1068 Inserm, UMR7258 CNRS, Aix Marseille University, Institut Paoli-Calmettes, Marseille, France.ORCID https://orcid.org/0000-0002-4103-7462

Funding

La Ligue Contre le Cancer GELI/2019National Research Foundation of Korea RS-2024-00454407National Research Foundation of Korea RS-2025-14383304National Research Foundation of Korea RS-2025-23323743Natural Sciences and Engineering Research Council of Canada RGPIN-2020-06924Swiss National Science Foundation 31003A_1327010Swiss National Science Foundation PP00A--102941/1Wellcome TrustWellcome Trust 10.35802/105256
6 · The paper itself

Abstract

Set1 is the catalytic subunit of SET1C or COMPASS, which methylates histone H3K4 and serves as a scaffold for the association of seven tightly bound polypeptides. We have employed yeast two-hybrid screenings to determine the interactome of Set1 and each subunit, providing a unique resource for exploring known and novel roles of the complex. Our screenings identified a multitude of potential interactors involved in chromatin regulation, DNA replication, meiotic breaks, and Ty transposition, processes previously associated with SET1C. Consistent with Set1 being an RNA-binding protein, the screens link SET1C to multiple aspects of RNA biogenesis, including pre-mRNA splicing and polyadenylation. The results reveal that several importins are candidate interactors of Set1, along with RGG motif-containing proteins, providing insights into the mechanisms by which Set1 moves between cytoplasmic and nuclear compartments. We further reveal that reconstituted SET1C interacts with the AT-hook domain of the chromatin remodeler Snf2 and methylates multiple arginines within this domain. In vivo, we report that the ARTSTRGR AT-hook motif is methylated in a Set1-dependent manner, revealing new interplay between lysine and arginine methylation.

Indexed as

Histone-Lysine N-MethyltransferaseSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsProtein BindingTwo-Hybrid System TechniquesHistone-Lysine N-MethyltransferaseSaccharomyces cerevisiae ProteinsSET1 protein, S cerevisiaegeneticsgenomicsinteractorsmethylationRGG motifRNA processingS. cerevisiaeSet1CSnf2

Identifiers

PMID42747427
PMCPMC13581290

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.